Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Rhodamine phalloidin-TRITC (AC147)
Cat.#: ASSD-147
Specifications
Description Rhodamine phalloidin-TRITC is a red-orange fluorescent cytoskeleton stain that binds and labels F-actin. Size 300 tests, 100μg Applications Used for tissue sections, cell cultures, and cell-free experiments samples. Chemical Name 7-[(4R)-5-[[[[4-[3,6-Bis(dimethylamino)xanthylium-9-yl]-3-carboxyphenyl]amino]thioxomethyl]amino]-4-hydroxy-L-leucine]phalloidin Molecule Weight 1231.4 Molecular formula C60H70N12O13S2 CAS Number 1926163-50-9 PubChem identifier 137247539 Purity >95% Solubility Soluble in DMSO Excitation ~540 nm Emission 565 nm Storage Store at -20° C Shipping Shipped at 4°C Important For our 300 tests pack, you should dissolve the compound in 1.5 mL of methanol or DMSO to make a stock solution. The product may appear colorless in very dry solvent. Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Size Price ASSD-155 Bromophenol blue (AC155) 5g inquiry ASSD-208 NBD-X, succinimidyl ester (AC208) 100 mg inquiry ASSD-181 Nitrofluorescein, Isomer 1 (AC181) 1 g inquiry ASSD-120 Fluorescent adenosine antagonist [XAC] (AC120) 500 μg inquiry ASSD-159 Erythrosin B (AC159) 1g, 5g inquiry ASSD-142 Methoxy-X04 (AC142) 10 mg, 50 mg inquiry ASSD-154 Brilliant Blue R-250 (AC154) 1g, 5g inquiry ASSD-140 A2B covalent ligand (AC140) 50 μg inquiry ASSD-207 NBD-X acid (AC207) 1 g inquiry ASSD-129 Fluorescent 5-HT1A antagonist [NAN-190] (AC129) 50 μg inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket